{
    "organizations": [],
    "uuid": "328e049b85b3f3f8f098cda3ddaaa8b26ed51653",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-atara-biotherapeutics-expands-t-ce/brief-atara-biotherapeutics-expands-t-cell-immunotherapy-collaboration-idUSFWN1SF0PV",
    "ord_in_thread": 0,
    "title": "BRIEF-Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Atara Biotherapeutics Inc:\n* ATARA BIOTHERAPEUTICS EXPANDS T-CELL IMMUNOTHERAPY COLLABORATION TO ADVANCE NEXT-GENERATION CAR T TECHNOLOGIES IN ONCOLOGY, AUTOIMMUNE AND OTHER DISEASES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T19:25:00.000+03:00",
    "crawled": "2018-05-09T12:36:27.030+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "atara",
        "biotherapeutics",
        "inc",
        "atara",
        "biotherapeutics",
        "expands",
        "immunotherapy",
        "collaboration",
        "advance",
        "car",
        "technology",
        "oncology",
        "autoimmune",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}